Virology of hepatitis C virus

Clinical Therapeutics

Volumn 18, Issue SUPPL. B, 1996, Pages 9-36

  Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN; VIRUS RNA;

BLOOD DONOR; CONFERENCE PAPER; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA TRANSLATION; SERODIAGNOSIS; TRANSFUSION; VIROLOGY; VIRUS GENOME; VIRUS REPLICATION;

EID: 0029959532     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80193-7     Document Type: Conference Paper

References (135)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science. 1989;244:359-362.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-364.
3. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 1991;88:2451-2455.
4. Rice CM, Lenches EM, Eddy SR, et al. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science. 1985;229: 726-733.
5. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA. 1990;87: 2057-2061.
6. Koonin EV. The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol. 1991; 72:2197-2206.
7. Tsukiyama Kohara K, Iizuka N, Kohara M. Internal ribosome entry site within hepatitis C virus RNA. J Virol. 1992;66: 1476-1483.
8. Brown EA, Zhang H, Ping H-L, Lemon SM. Secondary structure of the 5′ non-translated region of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res. 1992;20:5041-5045.
9. Wang CY, Sarnow P, Siddiqui A. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol. 1994;68:7301-7307.
10. Poole TL, Wang CY, Popp RA, et al. Pestivirus translation initiation occurs by internal ribosome entry. Virology. 1995;206: 750-754.
11. Miyamoto H, Okamoto H, Sato K, et al. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol. 1992;73: 715-718.
12. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA. 1995;92:3401-3405.
13. Felsenstein J. PHYLIP Inference Package Version 3.5. Seattle, Wash: Department of Genetics, University of Washington; 1993.
14. Shimizu YK, Iwamoto A, Hijikata M, et al. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA. 1992; 89:5477-5481.
15. Shimizu YK, Purcell RH, Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci USA. 1993; 90:6037-6041.
16. Carloni G, Iacovacci S, Sargiacomo M, et al. Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol. 1993;8(Suppl):31-39.
17. Shimizu YK, Yoshikura H. Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. J Virol. 1994;68:8406-8408.
18. Kato N, Nakazawa T, Mizutani T, Shimotohno K. Susceptibility of human t-lymphotropic virus type i infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun. 1995; 206:863-869.
19. Yoo BJ, Selby MJ, Choe J, et al. Transfection of a differentiated human hepatoma cell line (huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol. 1995; 69:32-38.
20. Lanford RE, Sureau C, Jacob JR, et al. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 1994;202:606-614.
21. Lau JYN, Krawczynski K, Negro F, Gonzalez-Peralta RP. In situ detection of hepatitis C virus: A critical appraisal. J Hepatol. In press.
22. Smith DB, Mellor J, Jarvis LM, et al. Variation of the hepatitis C virus 5′-non coding region: Implications for secondary structure, virus detection and typing. J Gen Virol. 1995;76:174-176.
23. Wang CY, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol. 1993;67:3338-3344.
24. Fukushi S, Katayama K, Kurihara C, et al. Complete 5′ noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem Biophys Res Commun. 1994;199:425-432.
25. Le SY, Sonenberg N, Maizel JV. Unusual folding regions and ribosome landing pad within hepatitis C virus and pestivirus RNAs. Gene. 1995;154:137-143.
26. Yoo BJ, Spaete RR, Geballe AP, et al. 5′ End-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology. 1992;191: 889-899.
27. Selby MJ, Choo QL, Berger K, et al. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol. 1993;74:1103-1113.
28. Ralston R, Thudium K, Berger K, et al. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol. 1993;67:6753-6761.
29. Grakoui A, Wychowski C, Lin C, et al. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993;67:1385-1395.
30. Hijikata M, Kato N, Ootsuyama Y, et al. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA. 1991;88:5547-5551.
31. Santolini E, Migliaccio G, Lamonica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994;68:3631-3641.
32. Mizushima H, Hijikata M, Tanji Y, et al. Analysis of n-terminal processing of hepatitis C virus nonstructural protein 2. J Virol. 1994;68:2731-2734.
33. Selby MJ, Glazer E, Masiarz F, Houghton M. Complex processing and protein:protein interactions in the e2:NS2 region of HCV. Virology. 1994;204:114-122.
34. Dubuisson J, Hsu HH, Cheung RC, et al. Formation and intracellular localization of hepatitis c virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. J Virol. 1994; 68:6147-6160.
35. Matsuura Y, Suzuki T, Suzuki R, et al. Processing of e1 and e2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology. 1994;205: 141-150.
36. Hijikata M, Mizushima H, Akagi T, et al. Distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993;67:4665-4675.
37. Eckart MR, Selby M, Masiarz F, et al. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun. 1993;192:399-406.
38. Grakoui A, McCourt DW, Wychowski C, et al. Characterization of the hepatitis C virus-encoded serine proteinase-determination of proteinase-dependent polyprotein cleavage sites. J Virol. 1993; 67:2832-2843.
39. Bartenschlager R, Ahlbornlaake L, Mous J, Jacobsen H. Nonstructural protein-3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol. 1993; 67:3835-3844.
40. Tomei L, Failla C, Santolini E, et al. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993;67:4017-4026.
41. Grakoui A, McCourt DW, Wychowski C, et al. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA. 1993; 90:10583-10587.
42. Lin C, Pragai BM, Grakoui A, et al. Hepatitis C virus NS3 serine proteinase: Trans-cleavage requirements and processing kinetics. J Virol. 1994;68:8147-8157.
43. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K. Identification of the domain required for trans-cleavage activity of hepatitis c viral serine proteinase. Gene. 1994;145:215-219.
44. Komoda Y, Hijikata M, Sato S, et al. Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coli. J Virol. 1994;68:7351-7357.
45. Kolykhalov AA, Agapov EV, Rice CM. Specificity of the hepatitis C virus NS3 serine protease: Effects of substitutions at the 3/4a, 4a/4b, 4b/5a, and 5a/5b cleavage sites on polyprotein processing. J Virol. 1994;68:7525-7533.
46. Bartenschlager R, Ahlbornlaake L, Yasargil K, et al. Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol. 1995;69:198-205.
47. Leinbach SS, Bhat RA, Xia SM, et al. Substrate specificity of the NS3 serine proteinase of hepatitis c virus as determined by mutagenesis at the NS3/NS4a junction. Virology. 1994;204:163-169.
48. Failla C, Tomei L, Defrancesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol. 1995;69: 1769-1777.
49. Tanji Y, Hijikata M, Satoh S, et al. Hepatitis C virus-encoded nonstructural protein NS4a has versatile functions in viral protein processing. J Virol. 1995;69:1575-1581.
50. Okamoto H, Kurai K, Okada S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology. 1992;188: 331-341.
51. Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105-1113.
52. Inchauspe G, Zebedee S, Lee DH, et al. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates. Proc Natl Acad Sci USA. 1991; 88:10292-10296.
53. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 1990;87:9524-9528.
54. Okamoto H, Kojima M, Sakamoto M, et al. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol. 1994;75:629-635.
55. Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol. 1991;72:2697-2704.
56. Sakamoto M, Akahane Y, Tsuda F, et al. The entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol. 1994;75:1761-1768.
57. Chayama K, Tsubota A, Koida I, et al. Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C. J Gen Virol. 1994;75:3623-3628.
58. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA. 1993;90:8234-8238.
59. Bukh J, Purcell RH, Miller RH. Sequence analysis of the core gene of 14 hepatitis c virus genotypes. Proc Natl Acad Sci USA. 1994;91:8239-8243.
60. Mellor J, Holmes EC, Jarvis LM, et al. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. J Gen Virol. 1995;76: 2493-2507.
61. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74:2391-2399.
62. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321-1324.
63. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990;170:1021-1025.
64. Chan S-W, McOmish F, Holmes EC, et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol. 1992;73: 1131-1141.
65. Chan SW, Simmonds P, McOmish F, et al. Serological responses to infection with three different types of hepatitis C virus. Lancet. 1991;338:1391. Letter.
66. Li J, Tong S, Vitvitski L, et al. Two French genotypes of hepatitis C virus: Homology of the predominant genotype with the prototype American strain. Gene. 1991;105: 167-172.
67. McOmish F, Chan S-W, Dow BC, et al. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993; 33:7-13.
68. Lee C, Cheng C, Wang J, Lumeng L. Identification of hepatitis C viruses with a non-conserved sequence of the 5′ untranslated region. J Clin Microbiol. 1992;30:1602-1604.
69. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA. 1992;89:4942-4946.
70. Cha TA, Beall E, Irvine B, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA. 1992;89:7144-7148.
71. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993; 74:1093-1102.
72. Kleter GEM, Van Doom LJ, Brouwer JT, et al. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in the Netherlands. J Clin Microbiol. 1994;33: 306-310.
73. Murphy D, Willems B, Delage G. Use of the 5′ non-coding region for genotyping hepatitis C virus. J Infect Dis. 1994; 169:473-475.
74. Tisminetzky SG, Gerotto M, Pontisso P, et al. Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C. Int Hepatol Commun. 1994;2:105-112.
75. Qu D, Hantz O, Gouy M, et al. Heterogeneity of hepatitis C virus genotypes in France. J Gen Virol. 1994;75:1063-I070.
76. Mahaney K, Tedeschi V, Maertens G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology. 1994; 20:1405-1411.
77. Saeed AA, al Admawi AM, al Rasheed A, et al. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet. 1991;338:459-460.
78. Darwish MA, Raouf TA, Rushdy P, et al. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993;49:440-447.
79. Kamel MA, Ghaffar YA, Wasef MA, et al. High HCV prevalence in Egyptian blood donors. Lancet. 1992;340:427. Letter.
80. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5′ non coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 1993; 74:661-668.
81. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol. 1994;32:884-892.
82. Ohno T, Mizokami M, Tibbs CJ, et al. New genotype of hepatitis C virus in South-Africa. J Med Virol. 1994;42: 409-413.
83. Nakao T, Enomoto N, Takada N, et al. Typing of hepatitis C virus (HCV) genomes by restriction fragment length polymorphisms. J Gen Virol. 1991;72: 2105-2112.
84. Kato N, Ootsuyama Y, Ohkoshi S, et al. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun. 1991; 181:279-285.
85. Takada N, Takase S, Enomoto N, et al. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol. 1992;14:35-40.
86. Liu K, Hu Z, Li H, et al. Genomic typing of hepatitis C viruses present in China. Gene. 1992;114:245-250.
87. Wang Y, Okamoto H, Mishiro S. HCV genotypes in China. Lancet. 1992;339: 1168. Letter.
88. Takada N, Takase S, Takada A, Date T. HCV genotypes in different countries. Lancet. 1992;339:808. Letter.
89. Takada N, Takase S, Takada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol. 1993;17:277-283.
90. Wang Y, Okamoto H, Tsuda F, et al. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol. 1993; 40:254-260.
91. Kinoshita T, Miyake K, Okamoto H, Mishiro S. Imported hepatitis C virus genotypes in Japanese hemophiliacs. J Infect Dis. 1993;168:249-250.
92. Chayama K, Tsubota A, Arase Y, et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol. 1993;8:150-156.
93. Davidson F, Simmonds P, Ferguson JC, et al. Survey of major genotypes and subtypes of hepatitis C virus using restriction fragment length polymorphism of sequences amplified from the 5′ non-coding region. J Gen Virol. 1995;76:1197-1204.
94. Mori S, Kato N, Yagyu A, et al. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun. 1992;183:334-342.
95. Tokita H, Shrestha SM, Okamoto H, et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol. 1994;75:931-936.
96. Tokita H, Okamoto H, Tsuda F, et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA. 1994;91:11022-11026.
97. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol. 1994;21:1-3.
98. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 1992;339: 1543. Letter.
99. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology. 1992;16:293-299.
100. Tsubota A, Chayama K, Arase Y, et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol. 1993;8: 535-539.
101. Dusheiko G, Schmilovitzweiss H, Brown D, et al. Hepatitis C virus genotypes - an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994;19:13-18.
102. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. NEJM. 1994;330:143. Letter.
103. Yamada G, Takahashi M, Miyamoto R, et al. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA. Dig Dis Sci. 1994;39:441. Letter.
104. Hino K, Sainokami S, Shimoda K, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 1994;42:299-305.
105. Chayama K, Arase Y, Koida I, et al. Antiviral effect of lymphoblastoid interferon-alpha on hepatitis C virus in patients with chronic hepatitis type C. J Gastroenterol Hepatol. 1994;9:128-133.
106. Tsubota A, Chayama K, Ikeda K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology. 1994;19:1088-1094.
107. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73:673-679.
108. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 1993;74:2385-2390.
109. Lau JYN, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 1995;171:281-289.
110. Bhattacherjee V, Prescott LE, Pike I, et al. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol. 1995;76:1737-1748.
111. Kato N, Ootsuyama Y, Ohkoshi S, et al. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun. 1992;189:119-127.
112. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA. 1992;89:3468-3472.
113. Kato N, Ootsuyama Y, Tanaka T, et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 1992;22:107-123.
114. Hijikata M, Kato N, Ootsuyama Y, et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun. 1991;175: 220-228.
115. Okamoto H, Kojima M, Okada SI, et al. Genetic drift of hepatitis-c virus during an 8.2-year infection in a chimpanzee - variability and stability. Virology. 1992;190:894-899.
116. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region-1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 1993;67:3923-3930.
117. Lesniewski RR, Boardway KM, Casey JM, et al. Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol. 1993;40:150-156.
118. Taniguchi S, Okamoto H, Sakamoto M, et al. A structurally flexible and antigenically variable n-terminal domain of the hepatitis C virus e2/NS1 protein - implication for an escape from antibody. Virology. 1993;195:297-301.
119. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (e2 NS1) in an agammaglobulinemic patient. Gastroenterology. 1994;106:1072-1075.
120. Okada S-I, Akahane Y, Suzuki H, et al. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viraemic patients. Hepatology. 1992;16:619-624.
121. Kumar U, Brown J, Monjardino J, Thomas HC. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis. 1993;167:726-730.
122. Higashi Y, Kakumu S, Yoshioka K, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 1993;197:659-668.
123. Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis-c virus in persons with chronic hepatitis. J Immunol. 1992;149: 3339-3344.
124. Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 1993;67:7522-7532.
125. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA. 1991;88: 3392-3396.
126. Cuypers HTM, Winkel IN, Vander Poel CL, et al. Analysis of genomic variability of hepatitis C virus. J Hepatol. 1991;13(Suppl):S15-S19.
127. Weiner AJ, Thaler MM, Crawford K, et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol. 1993;67:4365-4368.
128. Honda M, Kaneko S, Unoura M, et al. Risk of hepatitis C virus infections through household contact with chronic carriers - analysis of nucleotide sequences. Hepatology. 1993;17:971-976.
129. Chou WH, Lin SF, Sheu SH, et al. Comparison of hepatitis C virus strains obtained from hemodialysis patients. Jpn J Med Sci Biol. 1993;46:191-202.
130. Watanabe M, Ohkoshi S, Tawaraya H, et al. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion. 1994;34:125-129.
131. Allander T, Medin C, Jacobson SH, et al. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994;43:415-419.
132. Suzuki K, Mizokami M, Lau JYN, et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis. 1994;170:1575-1578.
133. Rice PS, Smith DB, Simmonds P, Holmes E. Heterosexual transmission of hepatitis C virus. Lancet. 1993;342:1052-1053.
134. Setoguchi Y, Kajihara S, Hara T, et al. Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol. 1994;9: 468-471.
135. Healey CJ, Smith DB, Walker JL, et al. Acute hepatitis C infection after sexual exposure. Gut. 1995;36:148-150.